PDCD1 and neoplasm: One of the most notable biomarkers in cancer research PD1, binds to its ligand PD-L1 and negatively regulates T cell activation, resulting in immune evasion; moreover, M2 macrophages’ ability to block tumor-specific T cell activity is thought to be via their influence on PD1 (64).